Taiwan FDA registration a1e801ad5a6de7ad8b85139fddc7c844
Longteng methamphetamine in vitro reagent group
TW: 龍騰甲基安非他命體外試劑組
Taiwan·Risk Class 2·Longteng Biotechnology Co., Ltd. new market factory·Registered Feb 24, 2020 – Feb 24, 2030ActiveRegistration details
- Analysis ID
- a1e801ad5a6de7ad8b85139fddc7c844
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Longteng Biotechnology Co., Ltd. new market factory
Product details
- Intended Use
- Qualitative detection of methamphetamine and its metabolites in human urine.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3610 Methamphetamine testing system
- Import Information
- Domestic
Dates and status
- Registration Date
- Feb 24, 2020
- Expiry Date
- Feb 24, 2030
About this record
Access comprehensive regulatory information for Longteng methamphetamine in vitro reagent group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number a1e801ad5a6de7ad8b85139fddc7c844 and manufactured by Longteng Biotechnology Co., Ltd. new market factory. The authorized representative in Taiwan is Longteng Biotechnology Co., Ltd. new market factory.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices